Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Astrotech Corp  (NASDAQ: ASTC)
 

ASTC's Revenue Growth by Quarter and Year

Astrotech's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ASTC Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter June 0.13
3rd Quarter March 0.34
2nd Quarter December 0.15
1st Quarter September 0.30
FY 0.92

ASTCs Annual Revenue
Astrotech's Revenue in the fiscal year 2026 $ 0.91 millions
Astrotech's Revenue in the fiscal year 2025 $ 1.05 millions
Astrotech's Revenue in the fiscal year 2024 $ 1.66 millions
Astrotech's Revenue in the fiscal year 2023 $ 0.75 millions
Astrotech's Revenue in the fiscal year 2022 $ 0.87 millions




ASTC Revenue fourth quarter 2025 Y/Y Growth Comment
Astrotech Corp reported fall in Revenue in the fourth quarter 2025 by -42.73% to $ 0.13 millions, from the same quarter in 2024.
The drop in the fourth quarter 2025 Astrotech Corp's Revenue compares unfavorably to the Company's average Revenue rise of 29.7%.

Looking into fourth quarter 2025 results within Laboratory Analytical Instruments industry 2 other companies have achieved higher Revenue growth. While Astrotech Corp' s Revenue drop of -42.73% ranks overall at the positon no. 1054 in the fourth quarter 2025.


ASTC Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter June -42.73 % 214.29 % -82.93 % 1950 %
3rd Quarter March -35.85 % 960 % 25 % -60 %
2nd Quarter December -42.31 % -76.79 % 330.77 % -53.57 %
1st Quarter September 900 % -93.02 % 975 % -78.95 %
FY   -11.92 % -37.72 % 122.67 % -

Financial Statements
Astrotech's fourth quarter 2025 Revenue $ 0.13 millions ASTC's Income Statement
Astrotech's fourth quarter 2024 Revenue $ 0.22 millions Quarterly ASTC's Income Statement


ASTC Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter June -62.94 % -58.49 % 40 % 925 %
3rd Quarter March 126.67 % 103.85 % -95.54 % -84.62 %
2nd Quarter December -50 % 766.67 % 160.47 % 550 %
1st Quarter September 36.36 % -57.14 % 4.88 % 100 %
FY (Year on Year)   -11.92 % -37.72 % 122.67 % -


Back to ASTC Growth rate Comparisons >> Back to ASTC Growth rate Comparisons >>


Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #203
Overall #1054

Revenue Y/Y Growth Statistics
High Average Low
456.67 % 29.7 % -96.88 %
(Mar 31 2024)   (Jun 30 2015)
Revenue fourth quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #3
Healthcare Sector #203
Overall #1054
Revenue Y/Y Growth Statistics
High Average Low
456.67 % 29.7 % -96.88 %
(Mar 31 2024)   (Jun 30 2015)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Astrotech's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
20400 % 442.65 % -100 %
(Dec 31 2019)  


ASTC's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Astrotech Corp disclosed fall in Revenue from the third quarter by -62.94% to $ 0.13 millions, from $ 0.34 millions achived in the previous reporting period.

But that's not important problem, as Astrotech's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 3759.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #549
Overall #3759
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #23
Healthcare Sector #549
Overall #3759
Revenue Q/Q Growth Statistics
High Average Low
20400 % 442.65 % -100 %
(Dec 31 2019)  


ASTC's IV. Quarter Q/Q Revenue Comment
In the IV. Quarter 2025 Astrotech Corp disclosed fall in Revenue from the third quarter by -62.94% to $ 0.13 millions, from $ 0.34 millions achived in the previous reporting period.

But that's not important problem, as Astrotech's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 22 other companies have achieved higher Revenue quarter on quarter growth. While Astrotech's Revenue growth quarter on quarter, overall rank is 3759.


Astrotech's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1.70 $ 1.01 $ 1.20 $ 1.31 $ 1.05
Y / Y Revenue Growth (TTM) 62.15 % 11.63 % 186.16 % 3.06 % -36.96 %
Year on Year Revenue Growth Overall Ranking # 3578 # 110 # 181 # 67 # 26
Seqeuential Revenue Change (TTM) 68.75 % -15.93 % -8.61 % 25.07 % 16.17 %
Seq. Revenue Growth (TTM) Overall Ranking # 1054 # 408 # 1800 # 2422 # 82


Cumulative Revenue growth Comment
Astrotech saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 62.15% year on year, to $ 2 millions if the fiscal year would have ended in Jun 30 2026.
Astrotech's trailing twelve months Revenue growth was higher than company's average 29.7% and higher than 11.63% growth in Mar 31 2026.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 68.75 % increase from $1.01 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 482 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 110 to 3578.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 483
Overall # 3578

Revenue TTM Y/Y Growth Statistics
High Average Low
456.67 %
 29.7 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 203
S&P 500 # 1054
Cumulative Revenue growth Comment
Astrotech saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 62.15% year on year, to $ 2 millions if the fiscal year would have ended in Jun 30 2026.
Astrotech's trailing twelve months Revenue growth was higher than company's average 29.7% and higher than 11.63% growth in Mar 31 2026.
The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 68.75 % increase from $1.01 millions in the period from Mar 31 2026 to Jun 30 2025.

In the Healthcare sector 482 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 110 to 3578.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 3
Healthcare Sector # 483
Overall # 3578

Revenue TTM Y/Y Growth Statistics
High Average Low
456.67 %
29.7 %
-96.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 203
S&P 500 # 1054




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ASTC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Bio rad Laboratories Inc -0.05%$ -0.046 millions
Seer Inc -0.29%$ -0.289 millions
Dyadic International Inc -0.57%$ -0.568 millions
Teva Pharmaceutical Industries Limited-0.81%$ -0.814 millions
Aytu Biopharma Inc-0.91%$ -0.911 millions
Neuropace Inc -1.32%$ -1.323 millions
Ardent Health Inc -1.40%$ -1.400 millions
Sunshine Biopharma Inc -1.56%$ -1.557 millions
Pacific Biosciences Of California Inc -1.71%$ -1.706 millions
United Therapeutics Corporation-1.92%$ -1.916 millions
Orasure Technologies Inc-1.93%$ -1.930 millions
Pulmonx Corporation-1.93%$ -1.931 millions
Volitionrx Limited-1.97%$ -1.975 millions
Organon and Co -2.26%$ -2.258 millions
Airsculpt Technologies Inc -2.53%$ -2.527 millions
Charles River Laboratories International inc -2.72%$ -2.718 millions
Perrigo Company Plc-3.17%$ -3.171 millions
Zai Lab Limited-3.33%$ -3.333 millions
Vanda Pharmaceuticals Inc -3.92%$ -3.919 millions
Teladoc Health Inc -3.95%$ -3.952 millions
Dentsply Sirona Inc -4.06%$ -4.060 millions
Sanuwave Health Inc -4.18%$ -4.181 millions
Treace Medical Concepts Inc -4.24%$ -4.244 millions
Fortrea Holdings Inc -4.52%$ -4.519 millions
Positron Corporation-6.91%$ -6.907 millions
Standard Biotools Inc -7.05%$ -7.046 millions
Inspire Medical Systems inc -7.32%$ -7.316 millions
Adapthealth Corp -7.50%$ -7.505 millions
China Pharma Holdings Inc-7.55%$ -7.548 millions
Skinhealth Systems Inc -7.68%$ -7.680 millions


About Astrotech Revenue Growth Rates (ASTC), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Astrotech Corp (CIK 1001907).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001437749-26-031175
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Astrotech Corp’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.